Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Courtney L Jones

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Nature Communications|September 14, 2018
Characterization and targeting of malignant stem cells in patients with advanced myelodysplastic syndromesBrett M Stevens, Nabilah Khan, Angelo D'Alessandro, et al.
Journal of Pediatric Hematology/Oncology|November 13, 2015
Genomic Characterization of Poorly Differentiated Neuroendocrine Carcinoma in a Pediatric PatientTeena Bhatla, Smita Dandekar, Benjamin Y Lu, et al.
Blood|May 19, 2019
Cysteine depletion targets leukemia stem cells through inhibition of electron transport complex IICourtney L Jones, Brett M Stevens, Angelo D'Alessandro, et al.
Blood|August 26, 2025
Plasma lipid levels predict chemotherapy response and survival in acute myeloid leukemiaCristiana O'Brien, Nirvana Nursimulu, Anit Tyagi, et al.
The Journal of Biological Chemistry|June 5, 2014
Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia modelCourtney L Jones, Teena Bhatla, Roy Blum, et al.
Cancer Cell|February 13, 2019
Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem CellsCourtney L Jones, Brett M Stevens, Angelo D'Alessandro, et al.
Cancer Cell|November 14, 2018
Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem CellsCourtney L Jones, Brett M Stevens, Angelo D'Alessandro, et al.
Nature Cancer|April 22, 2021
Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cellsBrett M Stevens, Courtney L Jones, Daniel A Pollyea, et al.
Experimental Hematology|July 8, 2022
Germline ETV6 mutation promotes inflammation and disrupts lymphoid development of early hematopoietic progenitorsChengjing Zhou, Rizvan Uluisik, Jesse W Rowley, et al.
Nature Medicine|November 14, 2018
Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemiaDaniel A Pollyea, Brett M Stevens, Courtney L Jones, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Nature Communications|September 14, 2018
Characterization and targeting of malignant stem cells in patients with advanced myelodysplastic syndromesBrett M Stevens, Nabilah Khan, Angelo D'Alessandro, et al.
Journal of Pediatric Hematology/Oncology|November 13, 2015
Genomic Characterization of Poorly Differentiated Neuroendocrine Carcinoma in a Pediatric PatientTeena Bhatla, Smita Dandekar, Benjamin Y Lu, et al.
Blood|May 19, 2019
Cysteine depletion targets leukemia stem cells through inhibition of electron transport complex IICourtney L Jones, Brett M Stevens, Angelo D'Alessandro, et al.
Blood|August 26, 2025
Plasma lipid levels predict chemotherapy response and survival in acute myeloid leukemiaCristiana O'Brien, Nirvana Nursimulu, Anit Tyagi, et al.
The Journal of Biological Chemistry|June 5, 2014
Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia modelCourtney L Jones, Teena Bhatla, Roy Blum, et al.
Cancer Cell|February 13, 2019
Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem CellsCourtney L Jones, Brett M Stevens, Angelo D'Alessandro, et al.
Cancer Cell|November 14, 2018
Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem CellsCourtney L Jones, Brett M Stevens, Angelo D'Alessandro, et al.
Nature Cancer|April 22, 2021
Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cellsBrett M Stevens, Courtney L Jones, Daniel A Pollyea, et al.
Experimental Hematology|July 8, 2022
Germline ETV6 mutation promotes inflammation and disrupts lymphoid development of early hematopoietic progenitorsChengjing Zhou, Rizvan Uluisik, Jesse W Rowley, et al.
Nature Medicine|November 14, 2018
Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemiaDaniel A Pollyea, Brett M Stevens, Courtney L Jones, et al.
Pageof 4